On the public citation graph
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.
0 signed · 514 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/978-1-4612-4380-9_37openalex-snapshot
Regression Models and Life-Tables
inferredcites →https://doi.org/10.1016/0021-9681(74)90015-0openalex-snapshot
The randomization and stratification of patients to clinical trials
inferredcites →https://doi.org/10.7326/0003-4819-114-9-819_4openalex-snapshot
Cancer: Principles and Practice of Oncology.
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4706360openalex-extracted
Standard or High Dose Chemoradiotherapy, with or Without the Protease Inhibitor Nelfinavir, for the Treatment of Locally Advanced Pancreatic Cancer: Efficacy, Safety and Health-Related Quality of Life Outcomes from the Multi-Centre Two Stage Phase 1/Randomised Phase 2 SCALOP-2 Study
inferred← citeshttps://doi.org/10.1001/jama.2016.4324openalex-snapshot
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
inferred← citeshttps://doi.org/10.1001/jamaoncol.2021.0028openalex-snapshot
Ablative Radiotherapy for Patients With Inoperable Pancreas Cancer—Ready for Prime Time?
inferred← citeshttps://doi.org/10.1001/jamasurg.2020.6273openalex-snapshot
Neoadjuvant Chemotherapy in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/(sici)1096-9098(199709)66:1<24::aid-jso6>3.0.co;2-popenalex-snapshot
Patterns of failure and long-term results in high-risk resected gastric cancer treated with postoperative radiotherapy with or without intraoperative electron boost
inferred← citeshttps://doi.org/10.1002/(sici)1097-0142(19960801)78:3+<674::aid-cncr12>3.0.co;2-3openalex-snapshot
Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinoma
inferred← citeshttps://doi.org/10.1002/(sici)1097-0142(19960801)78:3+<688::aid-cncr14>3.0.co;2-2openalex-snapshot
Systemic and adjuvant therapy for patients with pancreatic carcinoma
inferred← citeshttps://doi.org/10.1002/(sici)1097-0142(19960801)78:3<674::aid-cncr48>3.0.co;2-topenalex-snapshot
Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinoma
inferred← citeshttps://doi.org/10.1002/(sici)1097-0142(19960801)78:3<688::aid-cncr50>3.0.co;2-ropenalex-snapshot
Systemic and adjuvant therapy for patients with pancreatic carcinoma
inferred← citeshttps://doi.org/10.1002/(sici)1097-0142(20000315)88:6<1325::aid-cncr8>3.0.co;2-topenalex-snapshot
Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound?guided fine-needle injection in patients with advanced pancreatic carcinoma
inferred← citeshttps://doi.org/10.1002/1097-0142(19900401)65:7<1478::aid-cncr2820650705>3.0.co;2-3openalex-snapshot
Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The gastrointestinal tumor study group experience
inferred← citeshttps://doi.org/10.1002/14651858.cd002093.pub2openalex-snapshot
Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd002093.pub3openalex-snapshot
Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd011044.pub2openalex-snapshot
Chemotherapy and radiotherapy for advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/14651858.cd011044.pub3openalex-snapshot
Chemotherapy and radiotherapy for advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/9781118592168.ch6openalex-snapshot
Adenocarcinoma of the Pancreas
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm091openalex-snapshot
Carcinoma of the Stomach
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm091.pub2openalex-snapshot
Carcinoma of the Stomach
inferred← citeshttps://doi.org/10.1002/9781119756422.ch20openalex-snapshot
Management of Primary Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/ags3.70012openalex-snapshot
Role of radiotherapy in surgical approaches to pancreatic cancer treatment: A narrative review
inferred← citeshttps://doi.org/10.1002/bjs.1800810629openalex-snapshot
Chemotherapy prolongs survival in inoperable pancreatic carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.1553openalex-snapshot
Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/cam4.2021openalex-snapshot
Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial
inferred← citeshttps://doi.org/10.1002/cam4.4527openalex-snapshot
High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy
inferred← citeshttps://doi.org/10.1002/cncr.11165openalex-snapshot
Intraoperative and conformal external‐beam radiation therapy with protracted 5‐fluorouracil infusion in patients with locally advanced pancreatic carcinoma
inferred← citeshttps://doi.org/10.1002/cncr.22328openalex-snapshot
Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation
inferred← citeshttps://doi.org/10.1002/cncr.24059openalex-snapshot
Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas
inferred← citeshttps://doi.org/10.1002/cncr.24069openalex-snapshot
Stereotactic radiotherapy for pancreatic cancer?
inferred← citeshttps://doi.org/10.1002/cncr.25742openalex-snapshot
A phase 2 trial of gemcitabine, 5‐fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cncr.30780openalex-snapshot
Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/cncr.32756openalex-snapshot
Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1002/jso.23080openalex-snapshot
Randomized trials and quality assurance in gastric cancer surgery
inferred← citeshttps://doi.org/10.1002/jso.26202openalex-snapshot
Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: A NSQIP analysis
inferred← citeshttps://doi.org/10.1002/pro6.1080openalex-snapshot
Changing paradigm of radiation therapy for the treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1002/ssu.2980110212openalex-snapshot
Adjuvant and systemic therapy for pancreatic cancer
inferred← citeshttps://doi.org/10.1007/0-387-21600-6_21openalex-snapshot
Preoperative (Neoadjuvant) Therapy for Resectable Adenocarcinoma of the Pancreas
inferred← citeshttps://doi.org/10.1007/0-387-21600-6_28openalex-snapshot
Radiation Sensitizers, Fractionation Schedules, and Future Clinical Trials
inferred← citeshttps://doi.org/10.1007/0-387-31056-8_45openalex-snapshot
An Evidence-Based Approach to the Management of Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/174_2010_2openalex-snapshot
The Locally Advanced Nonmetastatic Cancer
inferred← citeshttps://doi.org/10.1007/174_2017_97openalex-snapshot
Gastrointestinal Cancer: Pancreas
inferred← citeshttps://doi.org/10.1007/3-540-27385-9_85openalex-snapshot
Neoplasien des Pankreas und der Gallenwege
inferred← citeshttps://doi.org/10.1007/3-540-35662-2_15openalex-snapshot
Novel Chemoradiation in Localized Pancreatic Cancer: Clinical Studies
inferred← citeshttps://doi.org/10.1007/978-0-387-69252-4_29openalex-snapshot
The Evolution of Chemoradiation Strategies for Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-0-387-69252-4_32openalex-snapshot
Neoadjuvant Treatment for Resectable and Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-0-387-77498-5_38openalex-snapshot
Developments in Chemoradiation for Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-0-85729-597-2_1openalex-snapshot
Introduction to Stereotactic Body Radiotherapy
inferred← citeshttps://doi.org/10.1007/978-1-4020-8900-8_22openalex-snapshot
Unresectable Locally Advanced Pancreatic Cancer: Concurrent Chemotherapy
inferred← citeshttps://doi.org/10.1007/978-1-4419-7358-0_17openalex-snapshot
Combined Modality Therapy in Cancer Management
inferred← citeshttps://doi.org/10.1007/978-1-4471-3356-8_9openalex-snapshot
Adjuvant Therapy After Resection of Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-1423-4_13openalex-snapshot
Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.1007/978-1-4939-6631-8_88-1openalex-snapshot
Role of Radiotherapy in Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-7193-0_88openalex-snapshot
Role of Radiotherapy in Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-1-59259-696-6_11openalex-snapshot
Gastric IORT With or Without EBRT
inferred← citeshttps://doi.org/10.1007/978-2-8178-0021-9_26openalex-snapshot
Chimiothérapie et radiothérapie des cancers pancréatiques
inferred← citeshttps://doi.org/10.1007/978-3-030-16924-4_20openalex-snapshot
Charged Particle Stereotactic Body Radiation Therapy
inferred← citeshttps://doi.org/10.1007/978-3-031-05494-5_17openalex-snapshot
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-031-05724-3_10openalex-snapshot
Management of Locally Advanced/Metastatic Disease: Radiation Oncology
inferred← citeshttps://doi.org/10.1007/978-3-031-05724-3_13openalex-snapshot
Management of Resectable and Borderline Resectable Disease: Radiation Oncology
inferred← citeshttps://doi.org/10.1007/978-3-031-61238-1_6openalex-snapshot
Gastrointestinal Malignancies: Pancreatic Cancer Clinical Trials in Neoadjuvant Chemotherapy
inferred← citeshttps://doi.org/10.1007/978-3-031-67743-4_19openalex-snapshot
Charged Particle Stereotactic Body Radiation Therapy
inferred← citeshttps://doi.org/10.1007/978-3-319-19677-0_18openalex-snapshot
Radiation Therapy for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-22780-1_8openalex-snapshot
Stereotactic Body Radiation Therapy as an Emerging Option for Localized Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-26067-9_17-1openalex-snapshot
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-26067-9_17-2openalex-snapshot
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-26067-9_17-3openalex-snapshot
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-26067-9_17-4openalex-snapshot
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-26236-9_17openalex-snapshot
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-540-28656-1_66openalex-snapshot
Management of Locally Advanced and Recurrent Pancreas Cancer
inferred← citeshttps://doi.org/10.1007/978-3-540-48554-4_85openalex-snapshot
Neoplasien des Pankreas und der Gallenwege
inferred← citeshttps://doi.org/10.1007/978-3-540-69886-9_24openalex-snapshot
Stereotactic Radiosurgery for Unresectable Adenocarcinoma of the Pancreas: Initial Experience at Sinai Hospital of Baltimore
inferred← citeshttps://doi.org/10.1007/978-3-540-71279-4_10openalex-snapshot
Primary Advanced Unresectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-642-04935-4_39openalex-snapshot
Chemotherapie beim Pankreaskarzinom
inferred← citeshttps://doi.org/10.1007/978-3-642-04935-4_44openalex-snapshot
Strahlentherapie in der Behandlung des Pankreaskarzinoms
inferred← citeshttps://doi.org/10.1007/978-3-642-13306-0_8openalex-snapshot
Unresectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-642-18700-1_42openalex-snapshot
Palliative Strahlentherapie
inferred← citeshttps://doi.org/10.1007/978-3-642-31629-6_16openalex-snapshot
Can Adjuvant Chemoradiotherapy Replace Extended Lymph Node Dissection in Gastric Cancer?
inferred← citeshttps://doi.org/10.1007/978-3-642-76187-4_20openalex-snapshot
Strahlentherapie des Magen-Karzinoms
inferred← citeshttps://doi.org/10.1007/978-3-642-80035-1_23openalex-snapshot
Chemotherapy for Patients with Adenocarcinoma of the Pancreas
inferred← citeshttps://doi.org/10.1007/978-3-642-83293-2_12openalex-snapshot
Treatment of Pancreatic Carcinoma: Therapeutic Nihilism?
inferred← citeshttps://doi.org/10.1007/978-3-642-83657-2_12openalex-snapshot
Medical Management of Gastrointestinal Cancer
inferred← citeshttps://doi.org/10.1007/978-3-662-12451-2_10openalex-snapshot
Erkrankungen von Leber, Gallenwegen und Pankreas
inferred← citeshttps://doi.org/10.1007/978-3-662-47181-4_37openalex-snapshot
Chemotherapy in the Management of Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-88-470-0856-4_37openalex-snapshot
Chemotherapy and Radiotherapy in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/bf00210792openalex-snapshot
A phase II study of weekly oral methotrexate and zidovudine (AZT) in advanced adenocarcinoma of the pancreas and hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/bf02307060openalex-snapshot
Treatment of adenocarcinoma of the stomach with resection, intraoperative radiotherapy, and adjuvant external beam radiation: A phase II study from radiation therapy oncology group 85-04
inferred← citeshttps://doi.org/10.1007/bf02785917openalex-snapshot
Results of adjuvant therapy in resected pancreatic cancer
inferred← citeshttps://doi.org/10.1007/bf02785921openalex-snapshot
Adjuvant chemotherapy in pancreatic cancer
inferred← citeshttps://doi.org/10.1007/bf02832103openalex-snapshot
La radioterapia en el cáncer gástrico
inferred← citeshttps://doi.org/10.1007/bf02924239openalex-snapshot
Overview of chemotherapy for pancreatic cancer
inferred← citeshttps://doi.org/10.1007/bf03045002openalex-snapshot
Therapie des Pankreasadenokarzinoms
inferred← citeshttps://doi.org/10.1007/s00066-008-1865-8openalex-snapshot
Radiotherapy in Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s00066-018-1281-7openalex-snapshot
Nonmetastatic pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00104-003-0614-xopenalex-snapshot
Adjuvante und additive Therapie beim Pankreaskarzinom
inferred← citeshttps://doi.org/10.1007/s00280-007-0647-9openalex-snapshot
Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas
inferred← citeshttps://doi.org/10.1007/s00280-008-0836-1openalex-snapshot
Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00280-009-0995-8openalex-snapshot
Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s00280-010-1365-2openalex-snapshot
Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas
inferred← citeshttps://doi.org/10.1007/s00280-012-1918-7openalex-snapshot
Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00280-014-2488-7openalex-snapshot
Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00280-018-3554-3openalex-snapshot
Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00423-018-1724-8openalex-snapshot
Neoadjuvant and adjuvant chemotherapy in pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00432-019-03066-zopenalex-snapshot
Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecitabine for locally advanced unresectable pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s005340050039openalex-snapshot
Evolving trends in combined modality therapy for pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00535-008-2236-zopenalex-snapshot
Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00535-009-0116-9openalex-snapshot
Clinical impact of radiotherapy for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s00595-026-03481-zopenalex-snapshot
A prospective open label, multicenter phase 2 trial of full-dose gemcitabine and S-1 concurrent with radiation for locally advanced pancreatic ductal adenocarcinoma (BR + UR-LA) (CSGO-HBP-008)
inferred← citeshttps://doi.org/10.1007/s007610050208openalex-snapshot
Gesicherte und überlegenswerte Indikationen zur Strahlentherapie beim Magenkarzinom
inferred← citeshttps://doi.org/10.1007/s10147-007-0739-xopenalex-snapshot
Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan
inferred← citeshttps://doi.org/10.1007/s10147-007-0763-xopenalex-snapshot
Chemoradiotherapy for unresectable pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s10147-012-0474-9openalex-snapshot
Performance status of patients is the major prognostic factor at all stages of pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s10269-015-2561-9openalex-snapshot
Place de la radiothérapie (et chimioradiothérapie) dans les cancers localement avancés ou borderline. Quelles perspectives ?
inferred← citeshttps://doi.org/10.1007/s11605-007-0110-6openalex-snapshot
Predicting Unresectability in Pancreatic Cancer Patients: The Additive Effects of CT and Endoscopic Ultrasound
inferred← citeshttps://doi.org/10.1007/s11605-010-1323-7openalex-snapshot
Image-Guided Stereotactic Radiosurgery for Locally Advanced Pancreatic Adenocarcinoma Results of First 85 Patients
inferred← citeshttps://doi.org/10.1007/s11845-018-1755-8openalex-snapshot
The emerging role of stereotactic radiotherapy in gastrointestinal malignancies: a review of the literature and analysis from the Irish perspective
inferred← citeshttps://doi.org/10.1007/s11912-002-0017-zopenalex-snapshot
Current and future strategies for combined-modality therapy in pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s11912-011-0164-1openalex-snapshot
Current Treatment Options for Pancreatic Carcinoma
inferred← citeshttps://doi.org/10.1007/s11912-014-0388-yopenalex-snapshot
Management Options in Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s11912-016-0499-8openalex-snapshot
Particle Radiation Therapy for Gastrointestinal Cancers
inferred← citeshttps://doi.org/10.1007/s12029-011-9251-7openalex-snapshot
Prospective Phase I Study of Capecitabine and Oxaliplatin Concurrent with Radiation Therapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma, and Retrospective Comparison to Concurrent 5-Fluorouracil/Radiation and Gemcitabine/Radiation
inferred← citeshttps://doi.org/10.1007/s12029-012-9419-9openalex-snapshot
Identification of Distinct Phenotypes of Locally Advanced Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s12029-015-9734-zopenalex-snapshot
A Meta-analysis of Randomized Clinical Trials of Chemoradiation Therapy in Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s12029-016-9821-9openalex-snapshot
Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience
inferred← citeshttps://doi.org/10.1007/s12094-014-1177-7openalex-snapshot
TTD consensus document on the diagnosis and management of exocrine pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s12325-015-0177-5openalex-snapshot
Current Adjuvant Therapeutic Approaches for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s12328-022-01621-9openalex-snapshot
Long-term survival after distal pancreatectomy with celiac axis resection and hepatic artery reconstruction in the setting of locally advanced unresectable pancreatic cancer
inferred← citeshttps://doi.org/10.1007/s13193-014-0371-yopenalex-snapshot
Advances in Chemotherapy for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s13566-017-0313-8openalex-snapshot
Clinical outcomes following stereotactic body radiation therapy (SBRT) for non-resectable pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1016/0360-3016(87)90347-6openalex-snapshot
Radiotherapy of gastric cancer with a three field combination: Feasibility, tolerance, and survival
inferred← citeshttps://doi.org/10.1016/0360-3016(94)90068-xopenalex-snapshot
Prospective phase I evaluation of radiation therapy, 5-fluorouracil, and levamisole in locally advanced gastrointestinal cancer
inferred← citeshttps://doi.org/10.1016/0360-3016(95)02032-2openalex-snapshot
A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma
inferred← citeshttps://doi.org/10.1016/0885-3924(88)90031-0openalex-snapshot
The role of radiation therapy in the control of pain from pancreatic carcinoma
inferred← citeshttps://doi.org/10.1016/0950-3528(90)90029-gopenalex-snapshot
Chemotherapy for pancreatic cancer
inferred← citeshttps://doi.org/10.1016/0950-3528(90)90030-kopenalex-snapshot
Radiotherapy in the treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1016/0959-8049(94)00445-5openalex-snapshot
No standard treatment is available for advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1016/0959-8049(94)90171-6openalex-snapshot
Neoadjuvant chemotherapy in locally advanced gastric carcinoma—a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum
inferred← citeshttps://doi.org/10.1016/b978-0-12-408103-1.00003-0openalex-snapshot
Multimodal Therapies for Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-803523-8.00015-0openalex-snapshot
Palliative Radiation Oncology for Gastrointestinal Tract Malignancies
inferred← citeshttps://doi.org/10.1016/b978-1-4160-5897-7.00038-xopenalex-snapshot
Cancer of the Stomach
inferred← citeshttps://doi.org/10.1016/b978-1-4160-5897-7.00039-1openalex-snapshot
Cancer of the Pancreas
inferred← citeshttps://doi.org/10.1016/b978-1-4377-1454-8.00063-1openalex-snapshot
Chemotherapy and radiotherapy for pancreatic and periampullary cancer
inferred← citeshttps://doi.org/10.1016/b978-3-437-21212-3.10017-7openalex-snapshot
Malignome des Gastrointestinaltrakts
inferred← citeshttps://doi.org/10.1016/b978-3-437-21212-3.10048-7openalex-snapshot
Literaturhinweise und Internetadressen
inferred← citeshttps://doi.org/10.1016/b978-3-437-21213-0.00017-6openalex-snapshot
Malignome des Gastrointestinaltrakts
inferred← citeshttps://doi.org/10.1016/b978-343723770-6.50021-1openalex-snapshot
Malignome des Gastrointestinaltrakts
inferred← citeshttps://doi.org/10.1016/j.adro.2017.01.003openalex-snapshot
Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.adro.2018.04.003openalex-snapshot
Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomes
inferred← citeshttps://doi.org/10.1016/j.adro.2023.101250openalex-snapshot
Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry
inferred← citeshttps://doi.org/10.1016/j.bbcan.2017.02.003openalex-snapshot
Biological determinants of radioresistance and their remediation in pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.bpg.2007.10.025openalex-snapshot
Pancreatic cancer: From pathogenesis to cure
inferred← citeshttps://doi.org/10.1016/j.canrad.2008.11.008openalex-snapshot
The integration of chemoradiation in the care of patient with localized pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.canrad.2010.10.001openalex-snapshot
Cancer du pancréas localement évolué non resécable : chimioradiothérapie d’induction suivie de chimiothérapie par gemcitabine contre chimiothérapie exclusive par gemcitabine : résultats définitifs de l’étude de phase III 2000–2001de la FFCD et de la SFRO
inferred← citeshttps://doi.org/10.1016/j.canrad.2018.06.005openalex-snapshot
Quelle place pour la radiothérapie dans la prise en charge des cancers du pancréas localisés ?
inferred← citeshttps://doi.org/10.1016/j.clcc.2023.01.002openalex-snapshot
The Current Role of Radiation in Pancreatic Cancer and Future Directions
inferred← citeshttps://doi.org/10.1016/j.clon.2008.02.003openalex-snapshot
Pancreatic Cancer within a UK Cancer Network with Special Emphasis on Locally Advanced Non-metastatic Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.clon.2008.03.004openalex-snapshot
Chemoradiotherapy for Locally Advanced Pancreatic Cancer: a Radiotherapy Dose Escalation and Organ Motion Study
inferred← citeshttps://doi.org/10.1016/j.clon.2009.12.003openalex-snapshot
Stereotactic Body Radiotherapy: A Review
inferred← citeshttps://doi.org/10.1016/j.clon.2010.06.007openalex-snapshot
Efficacy and Tolerability of Limited Field Radiotherapy with Concurrent Capecitabine in Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.clon.2014.06.002openalex-snapshot
Locally Advanced Pancreatic Cancer: The Role of Definitive Chemoradiotherapy
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2006.02.004openalex-snapshot
Current therapies and advances in the treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2007.08.002openalex-snapshot
Neoadjuvant treatment for pancreatic cancer—A review
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2008.01.009openalex-snapshot
Pancreatic cancer: Progress in cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ctro.2019.11.002openalex-snapshot
Influence of dose-averaged linear energy transfer on tumour control after carbon-ion radiation therapy for pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.ctro.2020.10.007openalex-snapshot
Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy
inferred← citeshttps://doi.org/10.1016/j.ctro.2021.02.004openalex-snapshot
Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network
inferred← citeshttps://doi.org/10.1016/j.currproblcancer.2017.10.006openalex-snapshot
Locally advanced pancreatic cancer: An emerging entity
inferred← citeshttps://doi.org/10.1016/j.currproblcancer.2020.100607openalex-snapshot
Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies
inferred← citeshttps://doi.org/10.1016/j.dld.2014.06.006openalex-snapshot
Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: A non-comparative randomized phase II trial
inferred← citeshttps://doi.org/10.1016/j.ejca.2015.12.026openalex-snapshot
Current standards and new innovative approaches for treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.gie.2011.10.007openalex-snapshot
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study
inferred← citeshttps://doi.org/10.1016/j.gtc.2011.12.004openalex-snapshot
Pancreatic Cancer: Medical Management (Novel Chemotherapeutics)
inferred← citeshttps://doi.org/10.1016/j.hoc.2006.01.005openalex-snapshot
The Effect of Radiation Therapy on Normal Tissue Function
inferred← citeshttps://doi.org/10.1016/j.hoc.2006.01.016openalex-snapshot
Radiation Therapy for Gastrointestinal Cancer
inferred← citeshttps://doi.org/10.1016/j.hoc.2015.04.005openalex-snapshot
Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2004.05.061openalex-snapshot
A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2004.12.074openalex-snapshot
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2006.08.070openalex-snapshot
The role of palliative radiation therapy in symptomatic locally advanced gastric cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2006.10.015openalex-snapshot
Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: A phase I-II study
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2006.12.053openalex-snapshot
Full-Dose Gemcitabine and Concurrent Radiotherapy for Unresectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2007.01.005openalex-snapshot
A Phase II Study of Fixed-Dose Rate Gemcitabine Plus Low-Dose Cisplatin Followed by Consolidative Chemoradiation for Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2008.04.012openalex-snapshot
Efficacy and Factors Affecting Outcome of Gemcitabine Concurrent Chemoradiotherapy in Patients With Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2008.07.015openalex-snapshot
Multicriteria Optimization in Intensity-Modulated Radiation Therapy Treatment Planning for Locally Advanced Cancer of the Pancreatic Head
showing the first 200 of 511 · page through all 511
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.